<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="eliminate">
            <roleset id="eliminate.01" name="remove&#x0A;" wordnet="1">
                <roles>
                    <role n="0" descr="entity removing&#x0A;" />
                    <role n="1" descr="thing being removed&#x0A;" />
                    <role n="2" descr="removed from&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>GntR binding to operators was eliminated by gluconate and also by 6-phosphogluconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>HBI site is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>One of the remaining three families had a 3-bp deletion in the chart that eliminated asparagine residue within product kinase domain; the other two had intronic mutations in or adjacent to the consensus dinucleotide sequences of splice-acceptor or donor sites, which probably would lead to aberrant defocusing.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>One of the remaining three families had a 3-bp deletion in the chart that eliminates asparagine residue within product kinase domain; the other two had intronic mutations in or adjacent to the consensus dinucleotide sequences of splice-acceptor or donor sites, which probably would lead to aberrant defocusing.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>One of the three remaining families carried a 3 bp deletion in frames that eliminated a sparring residue within a product kinase domain; the other two carried intonic mutations to or adjacent to the consensual dinucleotide sequences of acceptor or donor sites, which probably led to aberrant splicing.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, sec incorporation was completely eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these same mutations completely eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>T491 mutation eliminates recognition by anti-pT598 antibody, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>T491 mutation may eliminate recognition of anti-T598 antibodies while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>The asparagine residues within the product kinase domain was eliminated by the a 3 bp deletion in the graph; the other two showed intrinsic mutations in or adjacent to consensual dinucleotide sequences of acceptor or donor sites, which would probably lead to an aberrant blur.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>The fact that inhibits phosphorylation is eliminated is sufficient to confer constitutive activity in lin-45 Raf and induce multivulvated phenotypes in C.elegans.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>To eliminate inhibiating phosphorylation is sufficient to confer constitutive activity on the lin-45 Raf and induce multi-vulva phenotypes in C.elegans.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>development site III was eliminated by the others in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>hindIII site is eliminated by other in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>induction requirement is eliminated by mutation of a new locus, galS, resulting in constitutive and ultrainduced levels of gal expression.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>inhibition of any of these molecules is able to eliminate H(2)O(2) exogenous in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>inhibition of any of these molecules, as may occur after caspase activation, eliminates vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>receptors that activate microbe-detection immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>recognition was eliminated by mutation from T491 to antipT598 antibody while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>site of Ibavi was eliminated in exon 7 for a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>site of Ibavirin is eliminated in exon 7 by A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>the mutation of T491 has eliminated recognition for antipT598 antibody while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>the other would eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>the requirement of induction is eliminated by mutation of a new locus, gals, resulting in constitutive and ultrainduced levels of gal expression.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>the three sites eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A mutation has eliminated Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A mutation has eliminated site of Ibavirin into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A mutation is able to eliminate site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A mutation may eliminate Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>As illustrated in Figure 1, detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>As illustrated in Figure 1, gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators .</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>As illustrated in Figure 1, inhibition of any of these molecules eliminates viral stem cells .</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>As illustrated in Figure 1, insertion of 6-bp eliminates repression of the glpTQ promoter .</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>As illustrated in Figure 1, mutation of a new locus, galS eliminates induction requirement .</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>As illustrated in Figure 1, or any harmful effect is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>As illustrated in Figure 1, or any harmful effect was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>As illustrated in Figure 1, receptors that activate immune cells for microorganism detection eliminates pathogens .</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>As illustrated in Figure 1, receptors that activate microbe-detection immune cells eliminates pathogens .</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>As illustrated in Figure 1, stabilization observed with MG132 is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>As illustrated in Figure 1, the same mutations eliminates sec integration .</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>As illustrated in Figure 1, the three sites will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>BamiHI place is eliminated by a mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>BamiHI place is eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>BamiHI place is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>By eliminating the any deletion effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>By eliminating the the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>GntR connection to operators are eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>GntR connection to operators is eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>GntR connection to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>H(2)O(2) exogenous is eliminated in transgenic plants by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Ibavi site is eliminated by A mutation in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Ibavi site is eliminated by A mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Ibavi site is eliminated by A mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>In a molar ratio of 5:1 , it is observed that ligand is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>In a molar ratio of 5:1 , it is observed that round is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>In anti-ref1 antibody, formation of the nCaRE-protein complex will be completely eliminated (figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>In anti-retrof1, formation of the nCaRE-proteins complex will be completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>In antiref1 antibody , formation of the nCaRE-protein complex can be completely eliminated (Figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>In antiref1 antibody, formation of the nCaRE-protein complex will be completely eliminated (figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>In gluconate and also by 6-phosphogluconate, it is observed that GntR binding to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>In gluconate and also by 6-phosphoglyconate , GntR connection to operators can be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>In gluconate and also by 6-phosphoglyconate , it is observed that linking of GntR to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>In gluconate and also by 6-phosphoglyconate, GntR connection to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>In gluconate and also by 6-phosphoglyconate, linking of GntR to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>In gluconate and also by 6-phosphoglyconate, linking of GntR to operators will be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>In inhibition of any of these molecules , it is observed that viral stem cells is completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>In insertion of 6 bp, it is observed that repression of glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>In insertion of 6 bp, repression of the promoter glpTQ will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>In insertion of 6-bp , it is observed that repression of the glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>In insertion of 6-bp , it is observed that repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>In insertion of 6-bp , repression of glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>In insertion of 6-bp , repression of the glpTQ promoter can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>In insertion of 6-bp , repression of the glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>In microbe-detecting receptors that activated immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>In molar ratio of 5:1 , it is observed that arrangement is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>In molar ratio of 5:1 , it is observed that round is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>In mutation of a new locus, galS , induction requirement will be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>In receptors that activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>In receptors that activate microbe-detection immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>In receptors that activate microbe-detection immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>In six mutations , secrement is completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>In six mutations, sec incorporation will be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>In six mutations, secrement will be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>In staurosporin (or genestein; M-NEG data do not show), the stabilization observed with MG132 is completely eliminated (figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>In the gel-shift assay, antiref1 antibody will eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>In the gel-shift assay, detection receptors of micro-organisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>In the gel-shift assay, detection receptors of microorganisms such as CD14, which activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>In the gel-shift assay, detection receptors of microorganisms that activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>In the gel-shift assay, insertion of 6 bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>In the gel-shift assay, insertion of 6-bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>In the gel-shift assay, molar ratio of 5:1 eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>In the gel-shift assay, molar ratio of 5:1 eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>In the gel-shift assay, molar ratio of 5:1 will eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>In the gel-shift assay, receptors that activate immune cells for microorganism detection eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>In the gel-shift assay, receptors that activate microbe-detection immune cells will eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>In the gel-shift assay, six mutations will eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>In the gel-shift assay, the mutation of T491 will eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>In the ice change trial, a molar ratio of 5:1 has eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>In the ice change trial, detection receptors for microorganisms that activated immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>In the ice change trial, detection receptors of microorganisms that activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>In the ice change trial, gluconate and also by 6-phosphogluconate has eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>In the ice change trial, insertion of 6-bp has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>In the ice change trial, mutation of a new locus, galS has eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>In the ice change trial, six mutations has eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>In the ice change trial, these mutations has eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>In the ice shift test, detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>In the ice shift test, microbe-detecting receptors that activated immune cells eliminates pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>In the ice shift test, mutation of a new locus, galS eliminates induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>In the ice shift test, receptors that activate microbe-detection immune cells eliminates pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>In the ice shift test, six mutations eliminates secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>In the ice shift test, staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>In the ice shift test, the same mutations eliminates sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>In the ice-change test, anti-retrof1 will eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>In the ice-change test, detection receptors for microorganisms that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>In the ice-change test, insertion of 6-bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>In the ice-change test, mutation of a new locus, galS will eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>In the ice-change test, receptors that activate immune cells for microorganism detection will eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>In the ice-change test, staurosporin (or genestein; M-NEG data do not show) will eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>In the ice-change test, the mutation of T491 will eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>In the same mutations , it is observed that sec integration is completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>In the same mutations , sec integration can be completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>In the same mutations , sec integration is completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>In the same mutations, sec integration will be completely eliminated (figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>In the shift gel assay, detection receptors of microorganisms that activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>In the shift gel assay, mutation of a new locus, galS eliminates induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>In the shift gel assay, the mutation of T491 eliminates recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>In these mutations , it is observed that secincorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>In these same mutations , sec incorporation will be completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>In these same mutations, Sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>Insertion 6-bp, as may occur after activation of caspase, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Sec incorporation are eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Sec incorporation was eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, Insertion 6-bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a molar ratio of 5:1 can completely eliminate ligand (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a molar ratio of 5:1 can completely eliminate round (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, anti-ref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of microorganisms that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of microorganisms that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6 bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6-bp can completely eliminate repression of the glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, six mutations can completely eliminate secrement (Lesoon et al., 1997).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, staurosporin (or genestein; M-NEG data do not show) can completely eliminate the stabilization observed with MG132 (Lesoon et al., 1997).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphogluconate completely eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, inhibition of any of these molecules completely eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, molar ratio of 5:1 completely eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, anti-ref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, antiref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms that activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms that activated immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, galS completely removes the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, staurosporin (or genestein; M-NEG data do not show) completely removes the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, these mutations completely removes secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, GntR binding to operators was completely eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-proteins complex is completely eliminated by anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, induction requirement is completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, join was completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition for antipT598 antibody is completely eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the glpTQ promoter was completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, round is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, secincorporation is completely eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, viral stem cells is completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, viral stem cells was completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, vital stem cells was completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, anti-ref1 antibody completely eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, microbe-detecting receptors that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, galS completely eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of glpTQ promoter was completely eliminated to insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, sec incorporation was completely eliminated to these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these mutations completely eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these same mutations completely eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, viral stem cells was completely eliminated to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, vital stem cells was completely eliminated to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, GntR binding to operators is completely eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, Sec incorporation is completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, antiref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, formation of the nCaRE-protein complex is completely eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, gluconate and also by 6-phosphogluconate can completely eliminate GntR binding to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, inhibition of any of these molecules can completely eliminate vital stem cells (Lesoon et al., 1997).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6-bp can completely eliminate repression of glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, join is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, mutation of a new locus, galS can completely eliminate induction requirement (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, recognition by anti-pT598 antibody is completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of the glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, Insertion 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, antiref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphogluconate completely removes GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate completely removes GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate microbe-detection immune cells completely removes pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely removes secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the same mutations completely removes sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>T491 mutation has eliminated recognition into anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>T491 mutation is able to eliminate recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>T491 mutation located in O2 or between OT and O1 will eliminate recognition of anti-T598 antibodies, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>T491 mutation may eliminate recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>T491 mutation that eliminated recognition of anti-T598 antibodies was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>T491 mutation that eliminates recognition by anti-pT598 antibody is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>T491 mutation, as may occur after caspase activation, eliminates recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>The same high level of B-Raf activation occurs only when stabilization observed with MG132 were eliminated.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>They claim that a molar ratio of 5:1, as can occur after caspase activation, can eliminate ligand necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>They claim that anti-ref1 antibody, as can occur after caspase activation, can eliminate formation of the nCaRE-protein complex necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>They claim that detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>They claim that gluconate and also by 6-phosphogluconate, as can occur after caspase activation, can eliminate GntR binding to operators necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>They claim that insertion of 6 bp, as can occur after caspase activation, can eliminate repression of glpTQ promoter necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>They claim that molar ratio of 5:1, as can occur after caspase activation, can eliminate arrangement necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>They claim that molar ratio of 5:1, as can occur after caspase activation, can eliminate round necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>They established that a molar ratio of 5:1, as it can occur after activation of caspase, can eliminate ligand needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>They established that detection receptors for microorganisms such as CD14, which activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>They established that receptors that activate microbe-detection immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>They established that six mutations, as it can occur after activation of caspase, can eliminate sec incorporation needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>They established that the same mutations, as it can occur after activation of caspase, can eliminate sec integration needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>This eliminating by a molar ratio of 5:1 for the elimination of join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>This eliminating by insertion of 6-bp for the elimination of repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>This eliminating by insertion of 6-bp for the elimination of repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>This eliminating by molar ratio of 5:1 for the elimination of round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>This eliminating by receptors that activate microbe-detection immune cells for the elimination of pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>This eliminating by these mutations for the elimination of secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>This eliminating in detection receptors of microorganisms such as CD14, which activate immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>This eliminating in gluconate and also by 6-phosphogluconate for the removal of GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>This eliminating in receptors that activate immune cells for the removal of pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>This eliminating in receptors that activate microbe-detection immune cells for the removal of pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>This eliminating in the same mutations for the removal of sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>This eliminating in these same mutations for the removal of Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>This eliminating in these same mutations for the removal of sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>This occurs by Insertion 6-bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>This occurs by a molar ratio of 5:1 to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>This occurs by antiref1 antibody to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>This occurs by insertion of 6 bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>This occurs by microbe-detecting receptors that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>This occurs by mutation of a new locus, galS to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>This occurs by receptors that activate immune cells for microorganism detection to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>This occurs by these same mutations to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>This occurs in insertion of 6-bp to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>This occurs in receptors that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>To eliminate any harmful effect the same high level of B-Raf activation occurs.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>To eliminate stabilization seen with MG132 the same high level of B-Raf activation occurs.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>To eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>To eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>To eliminating the three sites that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>a molar ratio of 5:1 eliminates ligand while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>a molar ratio of 5:1 may eliminate ligand while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>a molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>a molar ratio of 5:1, such as CD14, is able to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>a mutation eliminate HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>a mutation is able to eliminate site of Ibavi into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>anti-ref1 antibody located in O2 or between OT and O1 will eliminate formation of the nCaRE-protein complex, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>anti-ref1 antibody may eliminate formation of the nCaRE-protein complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>anti-retrof1 eliminates formation of the nCaRE-proteins complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>anti-retrof1 located within O2 or between OT and O1 eliminates formation of the nCaRE-proteins complex, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>anti-retrof1 that eliminates formation of the nCaRE-proteins complex is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>anti-retrof1), formation of the nCaRE-proteins complex can be completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>antiref1 antibody has eliminated formation of the nCaRE-protein complex while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>antiref1 antibody located inside O2 or between OT and O1 eliminated formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>antiref1 antibody located inside O2 or between OT and O1 eliminates formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>antiref1 antibody removes formation of the nCaRE-protein complex eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>antiref1 antibody, as can occur after caspase activation, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>antiref1 antibody, as may occur after activation of caspase, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>arrangement is eliminated by molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>arrangement was eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>detection receptors for microorganisms that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>detection receptors for microorganisms that activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>detection receptors for microorganisms that activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>detection receptors for microorganisms that activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>detection receptors for microorganisms that activated immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>detection receptors for microorganisms that activated immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>detection receptors for microorganisms that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>detection receptors for microorganisms that activated immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>detection receptors of microorganisms that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>detection receptors of microorganisms that activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>detection receptors of microorganisms that activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>detection receptors of microorganisms that activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>detection receptors of microorganisms that activated immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>development site III is eliminated by the others to exon 11 of the phenylalanine hydroxylase gene, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>development site III is eliminated in exon 11 of the phenylalanine hydroxylase gene by the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>development site III was eliminated by the others to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>development site III was eliminated in exon 11 of the phenylalanine hydroxylase gene for the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>eliminate stabilization observed with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>eliminating or any harmful effect causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>eliminating stabilization observed with MG132 causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>exogeneous H(2)O(2) is eliminated by inhibition of any of these molecules via transgenic plants, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>exogeneous H(2)O(2) is eliminated in transgenic plants to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>exogeneous H(2)O(2) was eliminated by inhibition of any of these molecules to transgenic plants while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>exogeneous H(2)O(2) was eliminated in transgenic plants for inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>formation of the nCaRE-protein complex is eliminated by anti-ref1 antibody, as it may occur after activation of caspase.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody at a concentration of 10 times higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody, such as CD14.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>formation of the nCaRE-protein complex will be eliminated by anti-ref1 antibody at a concentration 10 times higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>formation of the nCaRE-proteins complex are eliminated by anti-retrof1, such as CD14.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>formation of the nCaRE-proteins complex has been eliminated by anti-retrof1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>formation of the nCaRE-proteins complex will be eliminated by anti-retrof1 at a concentration 10 times higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>gluconate and also by 6-phosphogluconate that eliminated GntR binding to operators was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>gluconate and also by 6-phosphogluconate that eliminates GntR binding to operators is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>gluconate and also by 6-phosphogluconate, such as CD14, eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>gluconate and also by 6-phosphoglyconate located in O2 or between OT and O1 will eliminate GntR connection to operators, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>gluconate and also by 6-phosphoglyconate located in O2 or between OT and O1 will eliminate linking of GntR to operators, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 will eliminate GntR connection to operators, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>gluconate and also by 6-phosphoglyconate removes linking of GntR to operators eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>gluconate and also by 6-phosphoglyconate that eliminates linking of GntR to operators is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, has eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after activation of caspase, is able to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, is able to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>hindIII site is eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>hindIII site is eliminated by the other via exon 11 of the gene for phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>hindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>hindIII site was eliminated in exon 11 of the gene for hydroxylase phenylalanine by other.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>hindIII site was eliminated in exon 11 of the phenylalanine hydroxylase gene by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>induction requirement is eliminated by mutation of a new locus, galS, as it may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>induction requirement was eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>inhibition of any of these molecules can eliminate viral stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>inhibition of any of these molecules can eliminate vital stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>inhibition of any of these molecules has eliminated exogeneous H(2)O(2) into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminated viral stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminated vital stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>inhibition of any of these molecules may eliminate viral stem cells while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>inhibition of any of these molecules that eliminates viral stem cells is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>inhibition of any of these molecules that eliminates viral stem cells is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>inhibition of any of these molecules that eliminates vital stem cells is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>inhibition of any of these molecules would eliminate H(2)O(2) exogenous in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>inhibition of any of these molecules, such as CD14, eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>insertion of 6 bp has eliminated repression of glpTQ promoter while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 eliminates repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>insertion of 6 bp removes repression of the promoter glpTQ eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>insertion of 6 bp that eliminated repression of the promoter glpTQ was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>insertion of 6 bp that eliminates repression of glpTQ promoter is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>insertion of 6 bp), repression of the promoter glpTQ can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>insertion of 6 bp, such as CD14, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>insertion of 6 bp, such as CD14, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>insertion of 6-bp has eliminated repression of the glpTQ promoter while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminated repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminates repression of the glpTQ promoter, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminates repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 will eliminate repression of the glpTQ promoter, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>insertion of 6-bp may eliminate repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>insertion of 6-bp removes repression of glpTQ promoter eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>insertion of 6-bp, such as CD14, eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>insertion of 6-bp, such as CD14, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>join has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>ligand are eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>ligand has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>ligand was eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>linking of GntR to operators will be eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>microbe-detecting receptors that activated immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>microbe-detecting receptors that activated immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>microbe-detecting receptors that activated immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>microbe-detecting receptors that activated immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>molar ratio of 5:1 eliminated arrangement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>molar ratio of 5:1 located in O2 or between OT and O1 will eliminate arrangement, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>molar ratio of 5:1 located within O2 or between OT and O1 eliminates arrangement, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>molar ratio of 5:1, as can occur after caspase activation, eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>molar ratio of 5:1, as can occur after caspase activation, has eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>mutation of a new locus, galS eliminated induction requirement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>mutation of a new locus, galS eliminated the requirement of induction while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>mutation of a new locus, galS eliminates the requirement of induction while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>mutation of a new locus, galS has eliminated induction requirement while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>mutation of a new locus, galS that eliminated the requirement of induction was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>mutation of a new locus, galS, as may occur after caspase activation, eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>other eliminate hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>other eliminated hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>other eliminated hindIII site into exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>pathogens are eliminated by microbe-detecting receptors that activated immune cells, such as CD14.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>pathogens has been eliminated by detection receptors of microorganisms that activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>pathogens has been eliminated by microbe-detecting receptors that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>pathogens has been eliminated by receptors that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>pathogens is eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>pathogens is eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>pathogens is eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>pathogens was eliminated by receptors that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>pathogens were eliminated by detection receptors for microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>pathogens will be eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>receptors that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>receptors that activate immune cells for microorganism detection eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>receptors that activate immune cells for microorganism detection may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>receptors that activate immune cells for microorganism detection that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>receptors that activate immune cells for microorganism detection), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>receptors that activate immune cells for microorganism detection, such as CD14, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>receptors that activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>receptors that activate microbe-detection immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>receptors that activate microbe-detection immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>receptors that activate microbe-detection immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>receptors that activate microbe-detection immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>recognition for antipT598 antibody will be eliminated by the mutation of T491 at a concentration 10 times higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation at a concentration of 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>recognition was eliminated by T491 mutation to anti-pT598 antibody while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>repression of glpTQ promoter has been eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>repression of the glpTQ promoter has been eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>repression of the glpTQ promoter will be eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>repression of the promoter glpTQ is eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>round are eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>round has been eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>round has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>round is eliminated by a molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>round is eliminated by molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>round is eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>round was eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>round will be eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>round will be eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>sec incorporation are eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>sec incorporation was eliminated by six mutations at a concentration of 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>sec incorporation was eliminated by these same mutations at a concentration of 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>sec integration are eliminated by the same mutations, such as CD14.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>sec integration was eliminated by the same mutations at a concentration 10 times higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>sec integration was eliminated by the same mutations at a concentration of 10 times higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>sec integration was eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>sec integration were eliminated by the same mutations, such as CD14.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>secincorporation was eliminated by these mutations at a concentration 10 times higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>secrement is eliminated by six mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>secrement was eliminated by six mutations at a concentration 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>secrement was eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>site HindIII was eliminated by the other to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>site HindIII was eliminated in exon 11 of the phenylalanine hydroxylase gene for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>site of Ibavi is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>site of Ibavi was eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>site of Ibavi was eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>six mutations can eliminate sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>six mutations eliminated secrement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>six mutations has eliminated secrement while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>six mutations located in O2 or between OT and O1 will eliminate sec incorporation, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>six mutations located in O2 or between OT and O1 will eliminate secrement, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>six mutations located inside O2 or between OT and O1 eliminates sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>six mutations that eliminates sec incorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>six mutations that eliminates secrement is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>six mutations, as may occur after activation of caspase, is able to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>six mutations, such as CD14, eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>stabilization observed with MG132 eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>staurosporin (or genestein; M-NEG data do not show) located within O2 or between OT and O1 has eliminated the stabilization observed with MG132, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>staurosporin (or genestein; M-NEG data do not show) that eliminated the stabilization observed with MG132 was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>staurosporin (or genestein; M-NEG data do not show), as may occur after caspase activation, eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>staurosporin (or genestein; M-NEG data do not show), such as CD14, eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>the HindIII site is eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>the HindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>the deleterious effects eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>the mutation of T491 eliminated recognition for antipT598 antibody while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>the mutation of T491 located inside O2 or between OT and O1 eliminated recognition for antipT598 antibody, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>the mutation of T491 located within O2 or between OT and O1 eliminates recognition for antipT598 antibody, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>the mutation of T491 removes recognition for antipT598 antibody eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>the mutation of T491 removes recognition for antipT598 antibody eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>the mutation of T491 that eliminates recognition for antipT598 antibody is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>the mutation of T491), recognition for antipT598 antibody can be completely eliminated (figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>the mutation of T491, such as CD14, is able to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>the other can eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>the other eliminate hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>the other eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>the other eliminated hindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>the other has eliminated hindIII site into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>the other has eliminated the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>the other is able to eliminate the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>the other may eliminate hindIII into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>the other may eliminate the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>the others is able to eliminate development site III into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>the others would eliminate development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>the same mutations eliminates sec integration while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>the same mutations located inside O2 or between OT and O1 eliminates sec integration, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>the same mutations located inside O2 or between OT and O1 will eliminate sec integration, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>the same mutations removes sec integration eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>the same mutations, as can occur after caspase activation, has eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>the same mutations, as may occur after activation of caspase, is able to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>the same mutations, such as CD14, eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>the stabilization observed with MG132 eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>these mutations can eliminate secincorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>these mutations has eliminated secincorporation while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>these mutations may eliminate secincorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>these mutations removes secincorporation eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>these mutations that eliminated secincorporation was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>these mutations, as may occur after activation of caspase, is able to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>these mutations, as may occur after caspase activation, eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>these same mutations eliminated sec incorporation while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>these same mutations located within O2 or between OT and O1 has eliminated sec incorporation, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>these same mutations that eliminates sec incorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>these same mutations, as can occur after caspase activation, is able to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>these same mutations, as may occur after caspase activation, eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>these same mutations, such as CD14, eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules at a concentration of 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>vital stem cells is eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>vital stem cells will be eliminated by inhibition of any of these molecules at a concentration 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>As illustrated in Figure 1, a 3 bp deletion in the graph eliminates asparagine residues .</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>As illustrated in Figure 1, a 3bp deletion in frames eliminates an asparagine residue .</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>As illustrated in Figure 1, inhibits phosphorylation is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>In a 3 bp deletion in frames , it is observed that a sparring residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>In a 3 bp deletion in frames, an asparaginal residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>In a 3 bp deletion in frames, it is observed that a sparring residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In a 3 bp deletion in the graph , asparagine residues can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In a 3 bp deletion in the graph, asparagine residues is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In a 3-bp deletion in the chart, asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>In a 3-bp deletion in the table , it is observed that asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In a 3-bp deletion in the table, asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In a 3-bp deletion in the table, it is observed that asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In a 3bp deletion in frames , an asparagine residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In a 3bp deletion in frames, a sparring residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>In a 3bp deletion in frames, an asparagine residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>In mutation of a new locus, gals , the requirement of induction can be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>In mutation of a new locus, gals, it is observed that the requirement of induction is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>In the gel-shift assay, a 3 bp deletion in the graph eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>In the gel-shift assay, a 3-bp deletion in the chart eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>In the ice shift test, a 3-bp deletion in the chart eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>In the ice-change test, a 3 bp deletion in frames will eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>In the ice-change test, a 3-bp deletion in the chart will eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>In the ice-change test, a 3bp deletion in frames will eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>In the shift gel assay, a 3-bp deletion in the table eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3 bp deletion in frames can completely eliminate an asparaginal residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3 bp deletion in the graph can completely eliminate asparagine residues (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3-bp deletion in the chart completely eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in the graph completely removes asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3bp deletion in frames completely removes a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue is completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue was completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residue is completely eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3bp deletion in frames completely eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, asparagine residue was completely eliminated to a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3-bp deletion in the chart can completely eliminate asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a sparring residue is completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in the graph completely removes asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>The same activation level of B-Raf occurs only when exogeneous H(2)O(2) has been eliminated.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>The same high level of B-Raf activation occurs only when inhibitory phosphorylation were eliminated.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>They claim that a 3 bp deletion in frames, as can occur after caspase activation, can eliminate a sparring residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>They claim that a 3 bp deletion in the graph, as can occur after caspase activation, can eliminate asparagine residues necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>They claim that a 3-bp deletion in the chart, as can occur after caspase activation, can eliminate asparagine residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>They claim that a 3bp deletion in frames, as can occur after caspase activation, can eliminate a sparring residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>This eliminating in a 3-bp deletion in the chart for the removal of asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>This occurs in a 3 bp deletion in frames to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>This occurs in a 3bp deletion in frames to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>To eliminate inhibiating phosphorylation the same high level of B-Raf activation occurs.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>To eliminating inhibits phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>a 3 bp deletion in frames eliminated an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>a 3 bp deletion in frames eliminates an asparaginal residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>a 3 bp deletion in frames has eliminated a sparring residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>a 3 bp deletion in frames located within O2 or between OT and O1 eliminates an asparaginal residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>a 3 bp deletion in frames may eliminate an asparaginal residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>a 3 bp deletion in frames removes a sparring residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>a 3 bp deletion in frames, such as CD14, eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>a 3 bp deletion in the graph located within O2 or between OT and O1 eliminates asparagine residues, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>a 3 bp deletion in the graph may eliminate asparagine residues into product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>a 3 bp deletion in the graph that eliminated asparagine residues was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>a 3 bp deletion in the graph that eliminates asparagine residues is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>a 3 bp deletion in the graph, such as CD14, eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>a 3 bp deletion in the graph, such as CD14, is able to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>a 3-bp deletion in the chart eliminates asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>a 3-bp deletion in the chart located in O2 or between OT and O1 will eliminate asparagine residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>a 3-bp deletion in the chart located within O2 or between OT and O1 eliminates asparagine residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>a 3-bp deletion in the chart removes asparagine residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>a 3-bp deletion in the chart would eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>a 3-bp deletion in the chart, as may occur after activation of caspase, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>a 3-bp deletion in the chart, as may occur after caspase activation, eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>a 3-bp deletion in the chart, such as CD14, can eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>a 3-bp deletion in the chart, such as CD14, eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>a 3-bp deletion in the table can eliminate asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>a 3-bp deletion in the table eliminates asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>a 3-bp deletion in the table may eliminate asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>a 3-bp deletion in the table may eliminate asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>a 3-bp deletion in the table that eliminated asparagine residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>a 3-bp deletion in the table, such as CD14, eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>a 3bp deletion in frames can eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>a 3bp deletion in frames eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>a 3bp deletion in frames eliminates a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>a 3bp deletion in frames has eliminated an asparagine residue into a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>a 3bp deletion in frames is able to eliminate a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>a 3bp deletion in frames is able to eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 eliminates a sparring residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 eliminates an asparagine residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 has eliminated a sparring residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>a 3bp deletion in frames that eliminated a sparring residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>a 3bp deletion in frames that eliminates an asparagine residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>a 3bp deletion in frames that eliminates an asparagine residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>a 3bp deletion in frames would eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, has eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>a 3bp deletion in frames, as may occur after activation of caspase, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>a 3bp deletion in frames, as may occur after activation of caspase, is able to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>a 3bp deletion in frames, such as CD14, can eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>a 3bp deletion in frames, such as CD14, eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>a 3bp deletion in frames, such as CD14, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>a sparring residue has been eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>an asparaginal residue is eliminated in a product kinase domain to a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>an asparaginal residue will be eliminated by a 3 bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames via a product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>an asparagine residue is eliminated in a kinase domain of the product to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>an asparagine residue was eliminated in a product kinase domain for a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>an asparagine residue will be eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart via product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>eliminate inhibiating phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>mutation of a new locus, gals, as may occur after caspase activation, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>the requirement of induction were eliminated by mutation of a new locus, gals, such as CD14.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
